The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.

Autor: Tward J; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: jonathan.tward@hci.utah.edu., Lenz L; Myriad Genetics, Inc, Salt Lake City, Utah., Flake DD II,; Myriad Genetics, Inc, Salt Lake City, Utah., Rajamani S; Myriad Genetics, Inc, Salt Lake City, Utah., Yonover P; UroPartners, Chicago, Illinois., Olsson C; Advanced Radiation Center of New York, New Hyde Park, New York, and Integrated Medical Professionals, North Hills, New York., Kapoor DA; Advanced Radiation Center of New York, New Hyde Park, New York, and Integrated Medical Professionals, North Hills, New York., Mantz C; 21st Century Oncology, Fort Meyers, Florida., Liauw SL; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, Illinois., Antic T; Department of Pathology, University of Chicago Medical Center, Chicago, Illinois., Fabrizio M; Urology of San Antonio, San Antonio, TX., Salzstein D; Urology of Virginia, Norfolk, Virginia., Shore N; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Albertson D; Department of Anatomic Pathology and Molecular Oncology, University of Utah, Salt Lake City, Utah., Henderson J; Regional Urology, LLC, Shreveport, Louisiana., Lee SP; Department of Radiation Oncology, Long Beach VA Medical Center, Long Beach, California., Gay HA; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Michalski J; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Hung A; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon., Raben D; University of Colorado, Aurora, Colorado., Garraway I; Department of Urology, Greater Los Angeles-VA Medical Center, Los Angeles, California., Lewis MS; Department of Urology, Greater Los Angeles-VA Medical Center, Los Angeles, California., Nguyen PL; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Marshall DT; Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina., Brawer MK; Myriad Genetics, Inc, Salt Lake City, Utah., Stone S; Myriad Genetics, Inc, Salt Lake City, Utah., Cohen T; Myriad Genetics, Inc, Salt Lake City, Utah.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 May 01; Vol. 113 (1), pp. 66-76. Date of Electronic Publication: 2021 Oct 03.